Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells

Virology

Volumn 360, Issue 1, 2007, Pages 172-181

  Milligan, Steven G ^a   Veerapraditsin, Thanaporn ^a   Ahamet, Boolang ^a   Mole, Sarah ^a   Graham, Sheila V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Human papillomavirus type 16; Promoter mapping; Putative novel proteins; Regulation of gene expression; Transcript mapping

Indexed keywords

MESSENGER RNA; POLYADENYLATED RNA; VIRUS RNA;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN W12; CONTROLLED STUDY; EPISOME; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMAN PAPILLOMAVIRUS TYPE 16; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; UTERINE CERVIX EPITHELIUM; VIRAL GENETICS; VIRUS EXPRESSION; VIRUS GENOME; VIRUS TRANSCRIPTION;

ALTERNATIVE SPLICING; CAPSID PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CERVIX UTERI; DNA PRIMERS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; POLYADENYLATION; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; RNA, MESSENGER; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33847350903     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.012     Document Type: Article

References (50)

1. Baker C.C., and Calef C. Maps of Papillomavirus mRNA Transcripts. III-3-III10 (1997), Los Alamos National Laboratories, Los Alamos, NM, USA
2. Baker C.C., and Howley P.M. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J. 6 (1987) 1027-1035
3. Boukamp P., Petrussevska R.T., Breitkreutz R., Horhung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalised aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
4. Choe J., Vaillancourt P., Stenlund A., and Botchan M.R. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 63 (1989) 1743-1755
5. Chow L.T., Nasseri M., Wolinsky S.M., and Broker T.R. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61 (1987) 2581-2588
6. Chow L.T., Reilly S.S., Broker T.R., and Taichman L. Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J. Virol. 61 (1987) 1913-1918
7. Crum C.P., Nuovo G., Freidman D., and Silverstein S.J. Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J. Virol. 62 (1988) 84-90
8. del Mar Pena L., and Laimins L.A. Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J. Virol. 75 (2001) 10005-10013
9. Doorbar J., Evans H.S., Coneron I., Crawford L., and Gallimore P.H. Analysis of HPV1 E4 gene expression using epitope-defined antibodies. EMBO J. 7 (1988) 825-833
10. Doorbar J., Parton A., Hartley K., Banks L., Crook T., Stanley M.A., and Crawford L. Detection of novel splicing patterns in an HPV-16-containing keratinocyte cell line. Virol. 178 (1990) 254-262
11. Doorbar J., Foo C., Coleman N., Medcalf E., Hartley O., Prospero T., Napthine S., Sterling J., Winter G., and Griffin H. Characterisation of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virol. 238 (1997) 40-52
12. Frattini M.G., Lim H.B., Doorbar J., and Laimins L.A. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71 (1997) 7068-7072
13. Garner-Hamrick P., and Fisher C. HPV episomal copy number closely correlates with cell size in keratinocyte monolayer cultures. Virology 301 (2002) 334-341
14. Geisen C., and Kahn T. Promoter activity of sequences located upstream of the human papillomavirus types 16 and 18 late regions. J. Gen. Virol. 77 (1996) 2193-2200
15. Glahder J.A., Hansen C.N., Vinther J., Madsen B.S., and Norrild B. A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA. J. Gen. Virol. 84 (2003) 3429-3441
16. Grassman K., Rapp B., Maschek H., Petry K.U., and Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70 (1996) 2339-2349
17. Howley P.M. Papillomavirinae: the viruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (1996), Lippincott-Raven Publishers, Philadelphia, PA 2045-2076
18. Hummel M., Hudson J.B., and Laimins L.A. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66 (1992) 6070-6080
19. Hummel M., Lim H.B., and Laimins L.A. Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol. 69 (1995) 3381-3388
20. Jeon S., Allen-Hoffman B.L., and Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69 (1995) 2989-2997
21. Karlsen S., Offord EA., and Beard. Functional promoters in the genome of human papillomavirus type 6b. J. Gen. Virol. 77 (1996) 11-16
22. Kennedy I.M., Haddow J.K., and Clements J.B. Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J. Virol. 64 (1990) 1825-1829
23. Kennedy I.M., Haddow J.K., and Clements J.B. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65 (1991) 2093-2097
24. Klumpp D.J., and Laimins L.A. Differentiation-induced changes in promoter usage for transcript encoding the human papillomavirus type 31 replication protein E1. Virol. 257 (1999) 239-246
25. Koffa M.D., Graham S.V., Takagaki Y., Manley J.L., and Clements J.B. The human papillomavirus type 16 negative regulatory element interacts with three proteins that act at different posttranscriptional levels. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4677-4682
26. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 15 (1991) 887-903
27. McBride A.A., Oliveira J.G., and McPhillips M.G. Partitioning viral genomes in mitosis. Cell Cycle 5 (2006) 1499-1502
28. McPhillips M.G., Veerapraditsin T., Cumming S.A., Karali D., Milligan S.G., Boner W., Morgan I.M., and Graham S.V. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during epithelial differentiation. J. Virol. 78 (2004) 10598-10605
29. Meyers C., Frattini M.G., Hudson J.B., and Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257 (1992) 971-973
30. Munger K., and Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 89 (2002) 213-228
31. Öberg D., Collier B., Zhao X., and Schwartz S. Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol. 77 (2003) 11674-11684
32. Ozbun M.A., and Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71 (1997) 5161-5172
33. Ozbun M.A., and Meyers C. Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation. J. Virol. 73 (1999) 3505-3510
34. Palermo-Dilts D.A., Broker T.R., and Chow L.T. Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts. J. Virol. 64 (1990) 3144-3149
35. Rohlfs M., Winkenbach S., Meyer S., Rupp T., and Dürst M. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virol. 183 (1991) 331-342
36. Ruesch M.N., Stubenrauch F., and Laimins L.A. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin. J. Virol. 72 (1998) 5016-5024
37. Sambrook J., Fritsch E., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York
38. Schneider-Gädicke A., and Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5 (1986) 2285-2292
39. Schwarz E., Freese U., Gissman L., Mayer W., Roggenbuck B., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
40. Sherman L., Alloul N., Golan I., Dürst M., and Baram A. Expression and splicing patterns of human papillomavirus type 16 mRNAs in pre-cancerous lesions and carcinoma of the cervix, in human keratinocytes immortalized by HPV 16 and in cell lines established from cervical cancers. Int. J. Cancer 50 (1992) 356-364
41. Smale ST. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochem. Biophys. Acta 1351 (1997) 73-88
42. Smotkin D., and Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4680-4684
43. Smotkin D., Prokoph H., and Wettstein F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63 (1989) 1441-1447
44. Stanley M.A., Browne H.M., Appelby M., and Minson A.C. Properties of a non-tumourigenic human cervical keratinocyte cell line. Int. J. Cancer 43 (1989) 672-676
45. Stoler M.H., Wolinsky S.M., Whitbeck A., Broker T.R., and Chow L.T. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridisation with message-specific RNA probes. Virology 172 (1989) 331-340
46. Stubenrauch F., and Laimins L.A. Human papillomavirus life cycle: active and latent phases. Seminars Cancer Biol. 9 (1999) 379-386
47. Tang S., Tao M., McCoy J.P., and Zheng Z.-M. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J. Virol. 80 (2006) 4249-4263
48. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer F.X., Shah K.V., Snijders P.J.F., Peto J., Meijer C.J.L.M., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
49. Zhao X., Oberg D., Rush M., Fay J., Lambkin H., and Schwartz S. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2 and polypyrimidine tract binding protein. J. Virol. 79 (2005) 4270-4288
50. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350